Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Advances in Spatial Genomics › BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech

BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech

Jun 22, 2020
|
staff reporter

NEW YORK – Single-cell assay developer BioSkryb announced Monday an exclusive agreement to license technology from St. Jude Children's Research Hospital that it plans to use in a diagnostic test to detect and define populations of cancer cells during treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

What's Popular?

In Sequencing

  1. Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

  2. Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood

    Premium

  3. FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.